The Cancer Genome Atlas (TCGA) project incorporated molecular data of 825 breast cancer patient samples across five technological platforms and rendered four distinct heterogeneous breast cancer subtypes: luminal A, luminal B, HER2-enriched, and basal-like [33]. This evidence concerns the gene ERBB2 and breast cancer.